In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Please provide your email address to receive an email when new articles are posted on . An updated guideline on the prevention and management of atrial fibrillation includes a new staging system to ...

Patients reported improvements of 99% in control of AFib and 93.1% relief of symptoms with the QDOT MICRO™ Catheter 1 Temperature control allows for the use of higher radiofrequency power in short ...

The heart rhythm disorder called atrial fibrillation (AFib) can affect people of any age, but is most common in older adults. It may start with a rapid heartbeat, a fluttering feeling in a person’s ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

LONDON -- Pulmonary vein isolation (PVI) produced real short-term improvements for people with atrial fibrillation (Afib or AF), according to the first sham-controlled trial on the subject. Continuous ...

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally ...